Multivariate analyses of FcγRIIIa polymorphisms adjusting for rituximab
| Variable . | Exp (coefficient) . | P . |
|---|---|---|
| EFS | ||
| FF vs VF/VV | 0.917 | .71 |
| Rituximab | 0.488 | < .001 |
| Interaction | 1.470 | .29 |
| PFS | ||
| FF vs VF/VV | 0.946 | .82 |
| Rituximab | 0.450 | < .001 |
| Interaction | 1.565 | .24 |
| OS | ||
| FF vs VF/VV | 1.15 | .610 |
| Rituximab | 0.64 | .017 |
| Interaction | 1.01 | .980 |
| Variable . | Exp (coefficient) . | P . |
|---|---|---|
| EFS | ||
| FF vs VF/VV | 0.917 | .71 |
| Rituximab | 0.488 | < .001 |
| Interaction | 1.470 | .29 |
| PFS | ||
| FF vs VF/VV | 0.946 | .82 |
| Rituximab | 0.450 | < .001 |
| Interaction | 1.565 | .24 |
| OS | ||
| FF vs VF/VV | 1.15 | .610 |
| Rituximab | 0.64 | .017 |
| Interaction | 1.01 | .980 |